WEBINAR

Advanced PGx: Drug-Drug Interactions & Polypharmacy

For clinicians managing polypharmacy patients, drug-drug interactions (DDIs) pose a significant challenge. Certain medications can inhibit or induce metabolic pathways, leading to reduced efficacy, heightened toxicity, or unexpected side effects.

This advanced CPD webinar builds upon foundational pharmacogenomics (PGx) knowledge, focusing on how drug metabolism, transport, and elimination are affected when multiple medications interact. You will gain practical insights into how PGx testing can optimise treatment decisions, reduce adverse drug reactions (ADR), and enhance patient safety.

22nd July 202522nd July 2025

Time: 12:30pmTime: 12:30pm

Duration: 45 minsDuration: 45 mins

Audience

DoctorsDoctors

Medical ProfessionalsMedical Professionals

Sign Up
Advanced PGx: Drug-Drug Interactions & Polypharmacy

Why Attend?

  • Polypharmacy is increasing – Over 50% of adults over 65 take five or more medications, raising the risk of DDIs.
  • DDIs can be fatal – ADRs cost the NHS an estimated £2 billion annually, with many linked to enzyme inhibition and altered metabolism.
  • PGx provides solutions – By understanding CYP450 enzyme interactions, drug transporters, and organ burden, you can personalise prescribing and avoid harmful interactions.

What You’ll Learn

PGx Basics

Understand key enzyme pathways and their impact on drug metabolism.

DDI Risks

Identify common drug-drug interactions and their clinical consequences.

CYP Enzymes

Learn how CYP2D6, CYP3A4, and CYP2C19 affect medication efficacy.

Case Studies

Explore real-world examples from psychiatry, cardiology, and pain management.

PGx in Practice

Apply PGx insights to reduce ADRs and personalise prescribing.

Certificate

Receive a Certificate of Attendance for CPD recognition.

Meet the Speakers

Prince Agyirey-Kwakye

Chief Scientific Officer

Simon Dean

CMO

LinkedIn

Register Now

This advanced CPD webinar builds upon foundational pharmacogenomics (PGx) knowledge, focusing on how drug metabolism, transport, and elimination are affected when multiple medications interact. You will gain practical insights into how PGx testing can optimise treatment decisions, reduce adverse drug reactions (ADR), and enhance patient safety.

Stay In The Loop

We'd like to send you occasional updates about this webinar and other services. Please confirm your consent to receive these communications by checking the box below.

I consent to receive communications about this webinar and other related content from AttoDiagnostics. I understand that I can unsubscribe at any time.